Recommendations for the management of autoinflammatory diseases

Nienke M. Ter Haar, Marlen Oswald, Jerold Jeyaratnam, Jordi Anton, Karyl S. Barron, Paul A. Brogan, Luca Cantarini, Caroline Galeotti, Gilles Grateau, Veronique Hentgen, Michael Hofer, Tilmann Kallinich, Isabelle Kone-Paut, Helen J. Lachmann, Huri Ozdogan, Seza Ozen, Ricardo Russo, Anna Simon, Yosef Uziel, Carine WoutersBrian M. Feldman, Sebastiaan J. Vastert, Nico M. Wulffraat, Susanne M. Benseler, Joost Frenkel, Marco Gattorno, Jasmin B. Kuemmerle-Deschner

Research output: Contribution to journalArticlepeer-review

Abstract

Autoinflammatory diseases are characterised by fever and systemic inflammation, with potentially serious complications. Owing to the rarity of these diseases, evidence-based guidelines are lacking. In 2012, the European project Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate regimens for the management of children and young adults with rheumatic diseases, facilitating the clinical practice of paediatricians and ( paediatric) rheumatologists. One of the aims of SHARE was to provide evidence-based recommendations for the management of the autoinflammatory diseases cryopyrin-associated periodic syndromes (CAPS), tumour necrosis factor (TNF) receptorassociated periodic syndrome (TRAPS) and mevalonate kinase deficiency (MKD). These recommendations were developed using the European League Against Rheumatism standard operating procedure. An expert committee of paediatric and adult rheumatologists was convened. Recommendations derived from the systematic literature review were evaluated by an online survey and subsequently discussed at a consensus meeting using Nominal Group Technique. Recommendations were accepted if more than 80% agreement was reached. In total, four overarching principles, 20 recommendations on therapy and 14 recommendations on monitoring were accepted with >80% agreement among the experts. Topics included (but were not limited to) validated disease activity scores, therapy and items to assess in monitoring of a patient. By developing these recommendations, we aim to optimise the management of patients with CAPS, TRAPS and MKD. This project is supported by a grant from European Agency for Health and Consumers (EAHC), grant number 2011 1202.

Original languageEnglish
Pages (from-to)1636-1644
Number of pages9
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number9
DOIs
Publication statusPublished - Sep 1 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy
  • Medicine(all)

Fingerprint Dive into the research topics of 'Recommendations for the management of autoinflammatory diseases'. Together they form a unique fingerprint.

Cite this